Inventor
MARELLA MICHAEL ANTHONY
US27 patents
⚠️ This page may combine multiple inventors who share the name “MARELLA MICHAEL ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADOLOR CORP
18 patentsUS6486165B2Nov 26, 2002
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP43 citations96
US5981513ANov 9, 1999
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP30 citations96
US5763445AJun 9, 1998
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP49 citations96
US5688955ANov 18, 1997
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP66 citations96
US6492351B1Dec 10, 2002
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP24 citations92
US6303611B1Oct 16, 2001
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP38 citations92
US6057323AMay 2, 2000
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP38 citations92
US6054445AApr 25, 2000
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritis therewith
ADOLOR CORP20 citations92
US5744458AApr 28, 1998
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP36 citations92
US6180623B1Jan 30, 2001
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP14 citations82
US6028063AFeb 22, 2000
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP15 citations82
US5945443AAug 31, 1999
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP14 citations82
US6239154B1May 29, 2001
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP11 citations74
US7294647B2Nov 13, 2007
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP1 citations63
US6391910B1May 21, 2002
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP5 citations63
US6960612B2Nov 1, 2005
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
ADOLOR CORP0 citations52
US6750216B2Jun 15, 2004
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP1 citations52
USRE38133EJun 3, 2003
Kappa agonist compounds and pharmaceutical formulations thereof
ADOLOR CORP1 citations52
WYETH CORP
6 patentsUS7317037B2Jan 8, 2008
Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
WYETH CORP69 citations95
US7618990B2Nov 17, 2009
Oxazolidone derivatives as PR modulators
WYETH CORP9 citations82
US7517899B2Apr 14, 2009
Phenylaminopropanol derivatives and methods of their use
WYETH CORP9 citations81
US7601722B2Oct 13, 2009
Aryl sulfamide derivatives and methods of their use
WYETH CORP2 citations51
US7618989B2Nov 17, 2009
Tricyclic oxazolidone derivatives useful as PR modulators
WYETH CORP0 citations40
US7538107B2May 26, 2009
Oxazinan-2-one derivatives useful as PR modulators
WYETH CORP0 citations40